Brian Corvese
Fortune : 664 385 $ au 31/05/2026
Fortune : 664 385 $ au 31/05/2026
Mr. Brian J.
Corvese is an Independent Non-Executive Director at Protagenic Therapeutics, Inc., an Independent Director at MiNK Therapeutics, Inc., an Independent Director at Agenus, Inc. and a President at Vencor Capital (Pty ) Ltd. He is on the Board of Directors at Protagenic Therapeutics, Inc., MiNK Therapeutics, Inc., Agenus, Inc. and National Telecommunications Corp.
Mr. Corvese was previously employed as a Portfolio Manager & Partner by Chancellor Capital Management, Inc. and a Managing Director & Partner by Soros Fund Management LLC.
He received his undergraduate degree from the University of Rhode Island.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MINK THERAPEUTICS, INC. 1,07 % | 01/06/2026 | 53 137 ( 1,07 % ) | 648 271 $ | 31/05/2026 |
AGENUS INC. 0,01 % | 24/04/2026 | 4 604 ( 0,01 % ) | 16 114 $ | 31/05/2026 |
| 30/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AGENUS INC. | Directeur/Membre du Conseil | 08/03/2007 |
| PROTAGENIC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/07/2017 |
| MINK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2017 |
National Telecommunications Corp.
National Telecommunications Corp. Miscellaneous Commercial ServicesCommercial Services Provides information services for business, electronic commerce, and circuit boards manufacturing. | Directeur/Membre du Conseil | - |
Vencor Capital (Pty ) Ltd. | Fondateur | 01/01/1999 |
| Sociétés | Poste | Fin |
|---|---|---|
Chancellor Capital Management, Inc.
Chancellor Capital Management, Inc. Investment ManagersFinance Investment advisors | Corporate Officer/Principal | 01/01/1996 |
Soros Fund Management LLC
Soros Fund Management LLC Investment ManagersFinance SFM aims to protect and grow Open Society’s resources. The firm invests globally in a wide range of strategies and asset classes, including public equities, fixed income, commodities, foreign exchange, alternative assets and private equity. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Chancellor Capital Management, Inc.
Chancellor Capital Management, Inc. Investment ManagersFinance Investment advisors | Finance |
Soros Fund Management LLC
Soros Fund Management LLC Investment ManagersFinance SFM aims to protect and grow Open Society’s resources. The firm invests globally in a wide range of strategies and asset classes, including public equities, fixed income, commodities, foreign exchange, alternative assets and private equity. | Finance |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Telecommunications Corp.
National Telecommunications Corp. Miscellaneous Commercial ServicesCommercial Services Provides information services for business, electronic commerce, and circuit boards manufacturing. | Commercial Services |
Vencor Capital (Pty ) Ltd. | |
Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national